TTCR Improvement Tafenoquine v Placebo
60 Degrees Pharmaceuticals Suspends Phase IIB Study of Tafenoquine for COVID-19, Pivots to Refocus on Commercialization of Treatments for Malaria and Tick-Borne Diseases
12. Oktober 2023 16:16 ET | Sixty Degrees Pharmaceuticals
60 Degrees Pharma Suspends Phase IIB COVID Study, Pivots to Commercialization of Treatments for Malaria and Tick-borne Illness
logo-brainhq-hi-res-hori.png
Surprising Study: Brain Exercise Helps with Knee Surgery Recovery
17. Juli 2023 07:55 ET | Posit Science
SAN FRANCISCO, July 17, 2023 (GLOBE NEWSWIRE) -- A new study, published in the journal Healthcare, somewhat surprisingly found that a small amount of brain training helped with recovery from knee...